STAT+: Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Category: Pharma
STAT+: Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
For the third time in less than a year, a group of lawmakers is urging…
STAT+: FDA scolds Sun Pharmaceutical for serious quality control problems at a key plant in India
Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food…
STAT+: Pharmalittle: FDA increasingly pauses trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug
Rise and shine, another busy day is on the way. We can tell if only…
STAT+: People hate drug ads on TV. Here’s what they complain about most
In the United States, pharmaceutical advertising seems inescapable. Since the first prescription drug ad ran…
STAT+: Moderna plans to follow in Pfizer’s footsteps, charge up to $130 for Covid-19 vaccine in U.S.
Moderna disclosed Monday that it plans to price its Covid-19 vaccine at anywhere from $110…
STAT+: Novavax replaces CEO, citing need for “fresh perspective”
The vaccine maker Novavax, which has faced several years of dramatic ups and downs around…
STAT+: A flurry of pharma acquisitions kick off JPM week after a slow year for deals
SAN FRANCISCO — Within the first hours of the J.P. Morgan Healthcare Conference, four life…
.jpg)
STAT+: Pharmalittle: Pediatricians recommend obesity drugs for children; as JPM starts, industry execs have a gloomy financing outlook
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
India’s lax oversight of pharmaceutical manufacturing imperils health around the world
Cough medicine tainted with ethylene glycol that killed at least 19 children in Uzbekistan in…
STAT+: The FDA has approved a new Alzheimer’s drug, but wide access may depend on CMS easing restrictions
Now that the U.S. Food and Drug Administration has granted accelerated approval to the widely…
STAT+: Pharmalittle: Pfizer scaling back early-stage research into rare diseases; BioNTech and U.K. partner on cancer trials
And so, another working week will soon draw to a close. Not a moment too…
Opinion: STAT+: Continuous manufacturing can help pharma companies save time, money, and more
The pharmaceutical industry has been slow to adopt a business practice that is faster, safer,…
STAT+: Pharma’s ambitious antibiotic venture fund makes another investment
For only the second time since launching nearly two years ago, the AMR Action Fund…
STAT+: Pharmalittle: New report gives glimpse into safety of an Alzheimer’s drug; Walgreens looks to dispense an abortion pill
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: 3 drug pricing issues to watch in 2023
WASHINGTON — The legislative saga on drug pricing is mostly over for now, but drug…
STAT+: ‘Stuck in a rut’: As debate flares over access to medicines, the future of voluntary licensing is up in the air
ANNECY, FRANCE — At first blush, the deal was hailed as a breakthrough. Last fall,…
STAT+: Pharmalittle: FDA rule change allows pharmacies to offer abortion pills; Medicare could have saved billions if inflationary rebate law existed
Top of the morning to you, and a fine one it is. Balmy breezes and…
STAT+: Medicare would have saved $3.7 billion on Part B drugs if inflationary rebates were around in a recent three-year period
If rebates had been required for price hikes on most of the nearly 100 medicines…
STAT+: Pharmalittle: Pharma plans to raise U.S. drug prices in January; U.S. sues AmerisourceBergen over opioid crisis
Good morning, everyone, and welcome to a new year. We hope the holiday respite was…
.jpg)
Wegovy may help obese teens lose weight but isn’t a magic bullet
The Food and Drug Administration’s approval of Wegovy, Novo Nordisk’s latest obesity drug, for adolescents…
FDA, Biogen, and an Alzheimer’s drug approval: 8 key takeaways from congressional investigation
Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug…
STAT+: ‘Rife with irregularities’: Congressional investigation reveals FDA’s approval of Aduhelm marked by secret discussions, breaches of protocol
WASHINGTON — The Food and Drug Administration’s review and approval of a controversial Alzheimer’s drug…
STAT+: Pharmalittle: FDA approves a Genentech blood-cancer drug; Sean Parker expands his immunotherapy research empire
Good morning, Pharmalittle family! Your loyal scribe Ed Silverman is taking today off, so he…
STAT+: Pharmalittle: Merck pays Chinese biotech $175 million for cancer drugs; who will make a gene therapy for very sick kids?
Good morning everyone! Matthew Herper is here, filling in for Pharmalot, who is taking a…
STAT+: California wants to revoke a CVS mail-order license for illegally filling opioid and ADHD prescriptions
California authorities are seeking to revoke a license held by a CVS Health mail-order pharmacy…
STAT+: Pharmalittle: ICER cuts cost-effective price for Pfizer Covid pill; McDonald’s sets targets to reduce antibiotic use in cattle
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: McDonald’s adds targets for limiting antibiotic use in beef to its menu, but doesn’t say when
After being accused of backtracking on a commitment to reduce its use of medically important…
STAT+: Pharmalittle: Pharma wins changes in bill concerning accelerated approval; pharmacy chains restrict purchases of pediatric pain relievers
Rise and shine, everyone, another busy day is on the way. And we can tell…
Pharma wins changes in bill regarding FDA’s accelerated approval
A bill that makes it easier for the Food and Drug Administration to withdraw drugs…
STAT+: Pharmalittle: FDA adds Lilly diabetes drugs to shortage list; WTO delays decision on extending Covid IP waiver
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Even with gene therapy on the horizon, drugmakers join hunt for new sickle cell drugs
Next year, two curative gene therapies could be approved for sickle cell disease. Yet drugmakers…
STAT+: Here are the finalists for best biopharma CEO of 2022. And a winner
It’s that time of the year again when we at STAT recognize the Best Biopharma…
STAT+: Eli Lilly diabetes drug Mounjaro in short supply, FDA says
The U.S. Food and Drug Administration has declared a shortage of Eli Lilly’s Mounjaro, the…
STAT+: Pharmalittle: AbbVie leaves pharma industry trade groups; net drug prices see big drop after inflation
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Drugmakers ask regulators to change standards on new Covid antibody drugs for most vulnerable
Biotech executives and a handful of academics pleaded with U.S. and European regulators on Thursday…
STAT+: Amid criticism over unaffordable insulin, Lilly strikes a manufacturing deal to supply Africa
In a bid to widen access to insulin in primarily low-income nations in Africa, Eli…
STAT+: Pharmalittle: U.S. prisons refuse to test and treat hepatitis C patients; HHS urges Supreme Court to reject Pfizer argument on Medicare kickbacks
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: Fixing price instability can improve access to affordable prescription drugs
The high cost of prescription drugs is a very real problem in the United States….
STAT+: Pharmalittle: Lawmakers accuse Pfizer of ‘pure greed’ over Covid vaccine price hike; Takeda to spend $4 billion on experimental pill
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Lawmakers tell Pfizer CEO to ‘back off’ on planned price hike for Covid-19 vaccine
A pair of U.S. lawmakers wrote Pfizer chief executive officer Albert Bourla that he should…
STAT+: Pharmalittle: Moderna and Merck vaccine lowers risk of skin cancer relapse; Cambodia halts exports of primates used for drug research
Top of the morning to you, and a fine one it is. Crystal clear blue…
STAT+: Amid fears of superbugs, sales of antibiotics used in food-producing livestock barely declined last year
Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock declined…
STAT+: Ongoing problems with a new European clinical trial registry could cause ‘catastrophe’
A coalition of pharmaceutical industry and academic medical research associations based in Germany is calling…
STAT+: Cambodia halts exports of non-human primates, threatening drug discovery efforts
Following the recent indictments of several people allegedly involved in a monkey-smuggling operation, Cambodia has…
STAT+: Pharmalittle: Amgen agrees to pay $27.8 billion for Horizon Therapeutics; Roche pharma head steps down
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Why a tone-deaf Regeneron executive deserved to be booed over Alzheimer’s drug pricing
File this under “What was he thinking?” The otherwise staid Milken Institute summit on health…
STAT+: Pharmalittle: Medicare willing to reevaluate coverage of Alzheimer’s drugs; judge tosses shingles-vaccine lawsuits against Merck
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Mark Cuban’s drug company goes after employer market; FDA slaps import alert on key Sun Pharma plant
Top of the morning to you, and a fine one it is. The sun is…
STAT+: Mark Cuban teams with a business coalition in bid to lower drug costs for employers
In his latest bid to expand access to lower-cost medicines, Mark Cuban’s Cost Plus Drug…